Diabetes drugs called GLP-1 agonists might help people overcome addictions by reducing how pleasurable substances like alcohol, nicotine, and opioids feel in the brain.
Evidence from Studies
Supporting (2)
Community contributions welcome
The study shows that people taking GLP-1 drugs (like those for diabetes) were less likely to develop substance use problems, including with alcohol, opioids, and nicotine. This supports the idea that these drugs may help reduce addiction.
GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives
The study shows that GLP-1 drugs, like those used for diabetes or weight loss, can reduce cravings for drugs and alcohol by affecting the brain’s reward system, which matches the claim.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.